Time-dependent propensity-matched general population study of the effects of statin use on cancer risk in an interstitial lung disease and pulmonary fibrosis cohort
Open accessThe DOI matches its Crossref record; 51 of the 53 references it cites were found in a registry or an index.
Abstract
Objective: To determine the effect of statins on risk of cancer in patients with interstitial lung disease (ILD) and pulmonary fibrosis. Setting: We retrospectively enrolled patients with ILD and pulmonary fibrosis and divided them into two cohorts by statin use (statin users (n=10 036) and statin non-users (n=10 036)). Participants: We selected patients with ILD and pulmonary fibrosis (N=53 862) from Taiwan’s National Health Insurance Research Database. Time-dependent Cox models were used to compare risk of cancer of propensity-matched statin users and non-users. Cumulative cancer incidence was analysed through Cox proportional regression. We calculated adjusted HRs (aHRs) and their 95% CIs for cancer after adjusting for sex, age, comorbidities, and use of inhaled corticosteroids, oral steroids and statins. Results: Compared with statin non-users, the aHRs (95% CIs) for statin users were 0.60 (0.55 to 0.65) for cancer, 0.52 (0.35 to 0.78) for haematological malignancy, 0.52 (0.38 to 0.72) for cancer of the head and neck, 0.73 (0.59 to 0.89) for colorectal cancer, 0.34 (0.26 to 0.43) for liver cancer, 0.39 (0.23 to 0.67) for pancreatic cancer, 0.40 (0.17 to 0.96) for skin cancer, 0.67 (0.52 to 0.87) for breast cancer, 0.27 (0.14 to 0.54) for cervical cancer, 0.37 (0.30 to 0.46) for other immunological cancers, 0.73 (0.54 to 0.98) for bladder/kidney cancer and 0.88 (0.71 to 1.09) for lung cancer. Conclusion: Statin use is associated with lower risk of cancer in the ILD and pulmonary fibrosis cohort.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“another study, this time of Taiwanese interstitial lung disease (ILD) and pulmonary fibrosis patients, reported a benefit of statin use in terms of PDAC incidence (adjusted HR 0.42, 95% CI 0.29–0.63) (Yeh et al., 2021).”
From The antitumoral effect of statins in pancreatic ductal adenocarcinoma: a scoping review (2026) · cites this paper as Yeh et al., 2021
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“That interpretation is supported by the lack of a similar association in the Hong Kong cohort reported by Xu et al. (2024), as well as by the opposite, apparently protective association observed by Yeh et al. in patients with ILD.”
From The antitumoral effect of statins in pancreatic ductal adenocarcinoma: a scoping review (2026) · cites this paper as Yeh et al., 2021
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Maringe, C., Spicer, J., Morris, M., Purushotham, A., Nolte, E., Sullivan, R., Rachet, B., & Aggarwal, A. (2020) · The Lancet Oncology · doi:10.1016/s1470-2045(20)30388-0 · Cited by 1,807
Global burden of cancers attributable to infections in 2012: a synthetic analysis
Plummer, M., de Martel, C., Vignat, J., Ferlay, J., Bray, F., & Franceschi, S. (2016) · The Lancet Global Health · doi:10.1016/s2214-109x(16)30143-7 · Cited by 1,635
Role of Matrix Metalloproteinases in Angiogenesis and Cancer
Quintero-Fabián, S., Arreola, R., Becerril-Villanueva, E., Torres-Romero, J. C., Arana-Argáez, V., Lara-Riegos, J., Ramírez-Camacho, M. A., & Alvarez-Sánchez, M. E. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.01370 · Cited by 1,036
Statin use and reduced cancer-related mortality
Nielsen, S. F., Nordestgaard, B. G., & Bojesen, S. E. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1201735 · Cited by 1,030 · cited 1×
“25 36–39 Nielsen et al 40 reported that patients who used statins (regardless of whether their daily dose level was low, moderate or high) exhibited a lower aHR for cancer-related mortality compared with those who did not use statins.”
Statin Use and Reduced Cancer-Related Mortality
(2013) · New England Journal of Medicine · doi:10.1056/nejmc1214827 · Cited by 720
Pulmonary Fibrosis in COVID-19 Survivors: Predictive Factors and Risk Reduction Strategies
Ojo, A. S., Balogun, S. A., Williams, O. T., & Ojo, O. S. (2020) · Pulmonary Medicine · doi:10.1155/2020/6175964 · Cited by 352
Metalloproteinases and Their Inhibitors: Potential for the Development of New Therapeutics
Raeeszadeh-Sarmazdeh, M., Do, L., & Hritz, B. (2020) · Cells · doi:10.3390/cells9051313 · Cited by 324
Ham, I.-H., Oh, H. J., Jin, H., Bae, C. A., Jeon, S.-M., Choi, K. S., Son, S.-Y., Han, S.-U., Brekken, R. A., Lee, D., et al. (2019) · Molecular Cancer · doi:10.1186/s12943-019-0972-8 · Cited by 264
The epidemiology of interstitial lung disease and its association with lung cancer
Raghu, G., Nyberg, F., & Morgan, G. (2004) · British Journal of Cancer · doi:10.1038/sj.bjc.6602061 · Cited by 213
Statin drugs to reduce breast cancer recurrence and mortality
Beckwitt, C. H., Brufsky, A., Oltvai, Z. N., & Wells, A. (2018) · Breast Cancer Research · doi:10.1186/s13058-018-1066-z · Cited by 197 · cited 1×
“Because the dynamic frequency of statin (hydrophilic and lipophilic statins) use may introduce bias to the study results, 17 we analysed statin use as a time-dependent covariate through the quantification of participants’ statin use status for every 6-month period.”
Cited by
Yeh, J., Liw, P.-X., Wong, Y., Kao, H.-M., Lee, C.-H., Lin, C., & Kao, C. (2024) · European journal of medical research · doi:10.1186/s40001-024-01836-1 · Cited by 14
“The coding of the IMIDs in the NHIRD was established according to these strict standard [55, 56].”
MethodSelf-citationSymvoulidis, P., Tsioutis, C., Zamboglou, C., & Agouridis, A. P. (2023) · Current Oncology · doi:10.3390/curroncol30070488 · Cited by 13
Park, J., Lee, C., Han, K., & Choi, S. M. (2024) · Scientific Reports · doi:10.1038/s41598-024-58417-9 · Cited by 10
“Statins are well-known to have cardiovascular protective effects and, in addition, a recent study using the Taiwan national health insurance database reported that statin use was associated with lower risk for lung cancers in patients with interstitial lung diseases 29 .”
ResultLi, R., Huang, G., Li, Y., Huang, M., Huang, Y., Li, Y., Li, G., & Song, W. C. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1427318 · Cited by 10
Bagheri, H., Adeli, O.-A., Heidari-Soureshjani, S., Azadegan-Dehkordi, Z., & Sherwin, C. M. T. (2024) · Current Drug Research Reviews · doi:10.2174/0125899775281869240311043637 · Cited by 8
Metadata
- Authors
- Yeh, J.-J., Lai, J.-N., Lin, C.-L., Hsu, C.-Y., & Kao, C.-H.
- Affiliations
- China Medical University (TW)
- Asia University (TW)
- Corresponding author
- Kao, Chia-Hung
- Venue
- BMJ Open
- Publisher
- BMJ
- Published
- 2021-10
- Volume
- 11
- Issue
- 10
- Pages
- e047039
- ISSN
- 2044-6055 (ISSN-L)
- PMC
- PMC8506875
- OpenAlex
- W3207715707
- Cited by
- 16
- References
- 53
- Citations by year
- 2026: 1 · 2025: 1 · 2024: 12 · 2023: 1 · 2022: 1
- FWCI
- 1.39
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- BMJ Open (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- China Medical University Hospital (DMR-110-089, DMR-109–231, MOST 108‐2321‐B‐039‐003)
- China Medical University
- Division of Materials Research
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Lipids, and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Keywords
- statins, cancer risk, interstitial lung disease, pulmonary fibrosis, hematologic malignancies, lung cancer, colorectal cancer, liver cancer, breast cancer, cervical cancer, skin cancer, immunosuppression
- MeSH terms
- Humans, Neoplasms, Pulmonary Fibrosis, Retrospective Studies, Cohort Studies, Incidence, Proportional Hazards Models, Lung Diseases, Interstitial, Hydroxymethylglutaryl-CoA Reductase Inhibitors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Time-dependent propensity-matched general population study of the effects of statin use on cancer risk in an interstitial lung disease and pulmonary fibrosis cohort. https://app.cochat.ai/papers/10.1136/bmjopen-2020-047039
- The paper
- Yeh, J.-J., Lai, J.-N., Lin, C.-L., Hsu, C.-Y., & Kao, C.-H. (2021). Time-dependent propensity-matched general population study of the effects of statin use on cancer risk in an interstitial lung disease and pulmonary fibrosis cohort. BMJ Open. https://doi.org/10.1136/bmjopen-2020-047039
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
